ABSTRACT
Research in the post-genome sequence era has been shifting towards a functional understanding of the roles and relationships between different genes in different conditions. While the advances in genetic expression profiling techniques including microarrays enable detailed and genome-scale measurements, the extraction of meaningful information from large datasets remains a challenging task. Here, we propose a novel method of generating gene differential expression profiles such that gene expression values from one dataset can be directly compared with those of another dataset. A simplified Discrete Fourier Transform is applied to interposed gene expression values, thereby generating the 'spectra' for a pair of conditions. Using this technique, differentially expressed genes produce higher amplitudes at the Nyquist Frequency. By measuring the phase of the 'spectra' generated, the over-and under-expressed nature of the genes can be identified. This method was validated using two sets of GeneChip array data, one from prostate cancer related dataset and the other from macular degeneration related dataset. The genes identified as differentially expressed by our method were found to be similar to those published using their preferred methods. Based on our findings, the proposed DFT method could be used efficiently in identifying differentially expressed genes from multiple-array experiments from two different conditions.
INTRODUCTION
The application of Discrete Fourier Transform (DFT) Theory in the analysis of microarray geneexpression data has been limited thus far. The theory has been applied in model-based methods of Luan and Li for identifying temporally expressed genes based on time course microarrays (1); DFT method of Wichert et al. in identifying temporally expressed transcripts in microarray time series data (2); Fourier harmonic approach of Zhang et al. for visualizing temporal pattern of gene expression (3); and DFT method of Shedden and Cooper for analysis of cell-cycle-specific gene expression in human cells (4) . It has become apparent that the cell-cycle specific genes are expressed in a temporal manner so that the Fourier Transform Theory can be applied. The limited DFT applications may be due to the lack of naturally formed waveforms within microarray expression data.
Depending on the underlying biological conditions, only a handful of genes are expected to have significant changes in their expression levels during the course of a microarray experiment. Many approaches have been described in the literature to detect the differentially expressed genes. These include fold change test and t-test by Long et al.(5) , significance analysis of microarray (SAM) by Tusher et al.(6) and ANOVA by Kerr et al.(7) . The fold change test has been popular mainly due to its simplicity. In this method, the potential candidates of differentially expressed genes are selected based on large fold change variation. If a selection is based on a single slide, the confidence level is low because real changes cannot be distinguished from experimental artifacts. Thus, the selected candidates of differentially expressed genes from single experiment have to be verified by repeating the experiment or by conducting experiments employing other methods such as Northern blotting.
Various
parametric-based models and nonparametric-based models were also developed to address the problem. Although each method has its own merits and produces reasonably good results, a good grasp of the complex models and knowledge in statistics is necessary to ensure correct and effective use of these approaches. Hence, a search for a simple and yet effective method is important for the advancement in this field of research. The method proposed here aims to achieve this very objective by applying a simplified DFT on intuitively arranged gene expression intensities from multiple microarray experiments.
MATERIALS AND METHODS
The proposed method uses Fourier Transform (FT) Theory and Sampling Theorem in detecting differentially expressed genes from microarray data. Since the data is processed in a computer, the Discrete FT is used instead of continuous FT. With a unique arrangement of the gene expression intensities and the use of Parseval's Theorem, the original DFT equation can be further simplified for ease of implementation and fast computation.
Discrete Fourier Transform
The Sampling Theorem states that for a limited bandwidth signal with maximum frequency component f max , the sampling frequency (f s ) used for capturing the signal must be greater than twice of that f max (i.e., f s > 2f max ), to prevent aliasing. The frequency 2f max is called the Nyquist sampling rate and half of this value, which is f max , is referred to as the Nyquist frequency. The The Discrete Fourier Transform (DFT) of f(x) is therefore given by:
Arrangement of Gene Expression Intensity and Its Transform
The proposed method describes a simple way of arranging two sets of microarray gene-expression data. The two sets of data could be derived from tissues under a pair of conditions, such as tumor versus normal or tumor x versus tumor y. For simplicity, the letters T and N are used to represent the two conditions. If there are M arrays, the gene-expression intensities are arranged in an interposed order, i.e., (T 1 N 1 )(T 2 N 2 )…(T M-1 N M-1 )(T M N M ) such that those of the second condition interpose the expression intensities from first condition. Table 1 shows a possible arrangement for M arrays of N genes each.
If a gene is consistently over-expressed in the T slides as compared to the N slides, the values in the columns T i will be constantly higher than those in the columns N i . The alternating expression intensities in T and N slides will then produce a consecutive high-low profile, which entails high DFT magnitude at the Nyquist frequency component. In Figure 1 , Data A is a plot of intensities of differentially expressed gene and Data B that of a non-differentially expressed gene. The magnitudes of the DFT on these two datasets are shown in Figure 2 . The frequency with the highest magnitude is f max located at the (M/2) th position. This frequency component is the Nyquist frequency. Likewise, if a gene is consistently underexpressed in T slides vis-à-vis the N slides, the alternating T and N slides will produce a consecutive low-high profile, which will generate high DFT magnitude at the Nyquist frequency component. In other words, a gene that is differentially expressed will present a zigzag waveform producing high DFT magnitude at the Nyquist frequency.
A quantitative measure of differentially expressed genes under two different conditions is described here. We normalize the magnitude of the Nyquist Frequency component to the sum of all the components. The normalized amplitude is defined as: The normalized amplitude becomes:
This simplification leads to a significant reduction in computational time. Instead of computing the complete N 0 points of DFT, we only need to compute one point, that of the Nyquist frequency component, and normalize it with the sum of the gene-expression as shown in equation (7). This normalized amplitude gives the ratio of the Nyquist Frequency magnitude to the sum of magnitudes. Indirectly it gives a score on the consistency of a gene being differentially expressed over the M slides in the microarray experiments.
In addition, a DFT on any data series results in complex values, i.e. F k = R k +J k i, where R k is the real value and J k is the imaginary value of the transformed F k , i defined as √(-1), represents the imaginary term. The phase of the component F k is computed as: Figure 3 shows two expression datasets, Data A represents under-expressed gene in T as compared to N condition, and Data C represents over-expressed gene in T-N conditions. Figure 4 shows the plot of the phase for the two transformed data series. It is interesting to note that the phase for the Nyquist component is -π radians for Data A (the under-expressed gene) and zero radian for Data C (the over-expressed gene). This property can be exploited in that a phase of zero radian at Nyquist component indicates an over-expressed gene, and that a phase of -π radian indicates an under-expressed gene. This feature removes the need to compute the ratios or the log ratios used in the popular fold-change method. The phase and normalized amplitude of the Nyquist Frequency component are sufficient for ferreting differentially expressed genes and determining whether they are over-or under-expressed genes.
The Scatter Plot of Normalized Amplitude Versus Absolute Amplitude
For the purpose of comparison, three common representations of differential gene expression are shown in Figure 5 . Figure 5a shows a scatter plot of microarray data where the Red intensity (R) is plotted against the Green intensity (G), the R and G intensities represent gene Figure 5b shows another scatter plot of microarray data where the logarithm of Red intensity (log 2 R) is plotted against the logarithm of Green intensity (log 2 G). Figure 5c shows a third scatter plot of microarray data where M is plotted against A. M is defined as log 2 C, where C = R/G, and A as (log 2 R + log 2 G)/2.
The use of DFT magnitude and phase presents more information visually. Figure 6 shows a plot where the normalized amplitude of the Nyquist frequency is plotted against the absolute amplitude. The normalized amplitudes of over-expressed genes, with phase equals zero radian , are set to positive values, and the normalized amplitudes of under-expressed genes, with phase equals -π radian, are set to negative values. In this novel representation, the differentially expressed genes are prominent and readily identified. In addition, the higher the magnitude of the normalized frequency component, the more consistent is the gene expression profile over the M slides. Similarly, the Figure 5 . Three different gene-expression plots visualizing the ratio and the log 2 (ratio) of gene expression intensities.
higher the magnitude of absolute amplitude, the higher is the fold changes between the T and N conditions. The novel plot also presents different quadrants that represent gene expression of different characteristics; genes located in the high normalized-amplitude and high absolute-amplitude quadrant will be best for use in clustering the microarray data. This plot complements well with the plots mentioned earlier.
RESULTS
To evaluate our method, we apply it to two published microarray datasets -a prostate cancer related dataset and a macular degeneration related dataset.
Performance on Prostate Cancer Datasets
T h e f i r s t d a t a s e t , t h e p r o s t a t e c a n c e r r e l a t e d d a t a s e t , w a s o b t a i n e d f r o m U R L : h t t p : / / w w w . b r o a d . m i t . e d u / c g ibin/cancer/publications/pub_paper.cgi?mode=view&pap er_id=75. In this study (11) , microarray expression analysis was used to identify genes that might anticipate the clinical behavior of prostate cancer. Singh et al. identified a set of genes that strongly correlated with the state of tumor differentiation, measured by Gleason score. The prediction result is shown in Table 2 .
This dataset contains gene expression data from 46 Affymetrix slides of prostate cancer tumor tissues and 46 slides of normal tissues. The expression intensities of the prostate cancer tissue and normal tissue were interposed in the manner as shown in Figure 1 . These interposed intensities were then subjected to DFT as described in the previous section. We identified the top 10 genes and used them for classification with Eisen's K-Means Cluster Program (12) . We successfully isolated the tumor slides from the normal slides with high prediction rate, as shown in Table 3 . Table 3a shows the prediction result without normalizing the data (raw values) and Table 3b shows the prediction result on mean-normalized data (i.e. the data is mean-normalized before using the proposed method). The prediction results, based on true-positive and true-negative tests, are 90.21% and 93.48% respectively for raw and normalized data. It is worth noting that 9 of our 18 top ranking genes are identical to those in the 16-gene model used by Singh et al. Table 4 summarizes the top 1  37639_at  x  10  39315_at  2  38634_at  x  11  40282_s_at  x  3  41152_f_at  12  1804_at  4  32598_at  x  13  31527_at  5  41706_at  14  38406_f_at  x  6  37366_at  15  39755_at  x  7  33656_at  16  40024_at  8  41468_at  x  17  39054_at  x  9  1740_g_at  18  38028_at  x Affy ID = Affymetrix Probe ID, x = found in Singh's 16-gene prediction model (11) . 18 genes identified using our method compared to those in Singh's model.
Performance on Age-Related Macular Degeneration Datasets
The second gene-expression data, macular disease related dataset, was obtained from public database published at the following URL: http://microarray.cnmcresearch.org/ListProjExp.asp?Pro jectName=WSilk+Macular+Degeneration, by Dr Karl GC. He conducted this experiment entitled 'Age-related macular degeneration has a strong epidemiological association with cardiovascular disease' at the National Eye Institute with the aim to identify disease-specific genes. Using microarray technology, 13 gene-expression data each were obtained from diseased and age-matched control patients. We applied our method to these data and identified top 10 ranking genes using our scoring method. These ten genes achieved 100% prediction rate in differentiating diseased samples from the control ones.
DISCUSSION
We discussed and presented two hypotheses. The first hypothesis describes a simplified DFT method that can be used for fast and efficient detection of differentially expressed genes from multiple microarray experiments. The second hypothesis reveals a new way in visualizing multiple microarray gene-expression intensities by plotting the normalized amplitude, incorporating phase information, against the absolute amplitude of the transformed intensities. It was shown in two real microarray datasets that this approach was able to detect consistently over-and under-expressed genes. It also showed that the method worked on both normalized and raw datasets. The scatter plot allows us to visualize genes of different expression modes plotted in different quadrants. Finally, the approach assumes that equal numbers of microarray experiments for tissues under two different conditions are conducted.
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